Page last updated: 2024-09-04

mk 767 and e 3040

mk 767 has been researched along with e 3040 in 1 studies

Compound Research Comparison

Studies
(mk 767)
Trials
(mk 767)
Recent Studies (post-2010)
(mk 767)
Studies
(e 3040)
Trials
(e 3040)
Recent Studies (post-2010) (e 3040)
320101801

Protein Interaction Comparison

ProteinTaxonomymk 767 (IC50)e 3040 (IC50)
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)0.1
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)0.165
Thromboxane-A synthase Homo sapiens (human)0.0495
Thromboxane-A synthaseRattus norvegicus (Norway rat)0.09
Leukotriene B4 receptor 1Homo sapiens (human)0.21

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morphy, R; Rankovic, Z1

Reviews

1 review(s) available for mk 767 and e 3040

ArticleYear
Designed multiple ligands. An emerging drug discovery paradigm.
    Journal of medicinal chemistry, 2005, Oct-20, Volume: 48, Issue:21

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors

2005